Gemtuzumab Ozogamicin 4.5 mg Suppliers & Bulk Manufacturers

Available Forms: Injection

Available Strengths: 4.5 mg

Reference Brands: Mylotarg (USA)

Category: Oncology Cancer Care

Gemtuzumab Ozogamicin is a Oncology Cancer Care product available as Injection in strengths 4.5 mg. It corresponds to the reference brand Mylotarg (USA). Verified GMP manufacturers and suppliers on PharmaTradz offer it in bulk for import worldwide, with regulatory documentation and dossier support available on request.

Product Description:

Gemtuzumab ozogamicin is a humanized monoclonal antibody–drug conjugate used in the treatment of acute myelogenous leukemia. It is designed to target CD33-positive leukemic cells, allowing the attached cytotoxic agent to be delivered directly into malignant cells. This targeted mechanism helps concentrate the therapeutic effect on cancer cells while reducing exposure to healthy tissues, making it an important option in specific leukemia treatment protocols.

During therapy, gemtuzumab ozogamicin has been associated with transient elevations in serum liver enzymes, reflecting its impact on hepatic function. In some patients, treatment has also been linked to the development of acute sinusoidal obstruction syndrome, a serious liver-related complication that may occur during or after therapy. While this condition is not uncommon, its severity can vary, and in rare cases it may be life-threatening.

Due to these potential risks, gemtuzumab ozogamicin is administered under strict medical supervision with careful patient selection and monitoring of liver function. It is typically used in specialized oncology settings where the benefits of targeted leukemia therapy can be balanced against the known safety considerations.